All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Corporate Bonds

GSK comes home for £1.4bn after five year absence

GlaxoSmithKline, the UK pharmaceutical company, launched its first sterling bonds today for nearly five years, achieving strong demand and raising £1.4bn in the second biggest corporate issue of the year in the currency.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree